The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population.
Open accessAbstract
We characterized the basis for the follicular lymphoproliferation in transgenic mice bearing a Bcl-2-immunoglobulin (Bcl-2-Ig) minigene representing the t(14;18) of human follicular lymphoma. Discriminatory S1 nuclease protection assays revealed that the Bcl-2-Ig transgene was overexpressed relative to endogenous mouse Bcl-2 in spleen and thymus. Western (immunoblot) analysis demonstrated the overproduction of the human 25-kilodalton Bcl-2 protein, which arose from the transgene, in spleen, thymus, and the expanded B-cell subset. Despite the generalized lymphoid pattern of deregulation, two-color flow cytometry and density gradient centrifugation indicated that the expanded lymphocytes were predominantly small, resting B cells coexpressing B220, immunoglobulin M (IgM), IgD, Ia, and kappa. Cell cycle analysis confirmed that about 97% of these expanded B cells reside in G0/G1. An extensive characterization of transgenic lines revealed a fourfold excess of IgM-IgD-expressing B cells in spleen and dramatically increased numbers in bone marrow. While resting, these cells proliferated in response to lipopolysaccharide and anti-IgM and demonstrated normal B-cell colony formation in soft agar. Moreover, these B cells, which demonstrated an extended survival in vitro even in the absence of stroma, were also resting in G0, yet were capable of proliferative responses. These findings provide consistent evidence that the accumulation of B cells after Bcl-2 overproduction is secondary to prolonged cell survival and not increased cell cycling. This suggests a unique role for Bcl-2 as a proto-oncogene that enhances cell survival independent of promoting cell division.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213
Self-citation
Cited by
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Self-citationBCL-2 FAMILY: Regulators of Cell Death
Chao, D. T., & Korsmeyer, S. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.395 · Cited by 1,685
Self-citationBCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.6961 · Cited by 1,252
Self-citationbcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O., & Korsmeyer, S. J. (1991) · Cell · doi:10.1016/0092-8674(91)90361-2 · Cited by 1,194
Self-citationBmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF
Jacobs, J. J. L., Scheijen, B., Voncken, J.-W., Kieboom, K., Berns, A., & van Lohuizen, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2678 · Cited by 1,065
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
Strasser, A., Harris, A. W., & Cory, S. (1991) · Cell · doi:10.1016/0092-8674(91)90362-3 · Cited by 1,054
MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
Kozopas, K. M., Yang, T., Buchan, H. L., Zhou, P., & Craig, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3516 · Cited by 961
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
Strasser, A., Harris, A. W., Bath, M. L., & Cory, S. (1990) · Nature · doi:10.1038/348331a0 · Cited by 905
Strasser, A., Whittingham, S., Vaux, D. L., Bath, M. L., Adams, J. M., Cory, S., & Harris, A. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8661 · Cited by 862
McDonnell, T. J., & Korsmeyer, S. J. (1991) · Nature · doi:10.1038/349254a0 · Cited by 858
Self-citationProteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
BCL-2 GENE FAMILY IN THE NERVOUS SYSTEM
Merry, D. E., & Korsmeyer, S. J. (1997) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.20.1.245 · Cited by 588
Self-citationThe proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis
Allsopp, T. E., Wyatt, S., Paterson, H. F., & Davies, A. M. (1993) · Cell · doi:10.1016/0092-8674(93)90230-n · Cited by 575
Waters, J. S., Webb, A., Cunningham, D., Clarke, P. A., Raynaud, F., di Stefano, F., & Cotter, F. E. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1812 · Cited by 454
Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.
Goodnow, C. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2264 · Cited by 446
Merry, D. E., Veis, D. J., Hickey, W. F., & Korsmeyer, S. J. (1994) · Development · doi:10.1242/dev.120.2.301 · Cited by 426
Self-citationRegulation of Lymphocyte Survival by the BCL-2 Gene Family
Cory, S. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.513 · Cited by 401
Bcl-XL and Bcl-2 repress a common pathway of cell death.
Chao, D. T., Linette, G. P., Boise, L. H., White, L. S., Thompson, C. B., & Korsmeyer, S. J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.821 · Cited by 395
Self-citationCell cycle deregulation in B-cell lymphomas
Sánchez-Beato, M., Sánchez-Aguilera, A., & Piris, M. A. (2003) · Blood · doi:10.1182/blood-2002-07-2009 · Cited by 358
Levy, Y., & Brouet, J. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116977 · Cited by 340
Genaro, A. M., Hortelano, S., Alvarez, A., Martínez, C., & Boscá, L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117869 · Cited by 337
The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies
Willis, T. G., & Dyer, M. J. S. (2000) · Blood · doi:10.1182/blood.v96.3.808 · Cited by 323
Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes.
Merino, R., Ding, L., Veis, D. J., Korsmeyer, S. J., & Nuñez, G. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06307.x · Cited by 301
Self-citationIqbal, J., Neppalli, V. T., Wright, G., Dave, B. J., Horsman, D. E., Rosenwald, A., Lynch, J., Hans, C. P., Weisenburger, D. D., Greiner, T. C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4264 · Cited by 298
Transgenic Models of Tumor Development
Adams, J. M., & Cory, S. (1991) · Science · doi:10.1126/science.1957168 · Cited by 280
Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family
Korsmeyer, S. J., Yin, X.-M., Oltvai, Z. N., Veis-Novack, D. J., & Linette, G. P. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00011-r · Cited by 272
Self-citationbcl-2 transgene expression can protect neurons against developmental and induced cell death.
Farlie, P. G., Dringen, R., Rees, S. M., Kannourakis, G., & Bernard, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4397 · Cited by 252
Metadata
- Authors
- McDonnell, T. J., Nunez, G., Platt, F. M., Hockenberry, D., London, L., McKearn, J. P., & Korsmeyer, S. J.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1990-05
- Volume
- 10
- Issue
- 5
- Pages
- 1901-1907
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2125111536
- Cited by
- 221
- References
- 1
- FWCI
- 20.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.